share_log

AnPac Bio-Medical Science In Dec 2022 & Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors; Investors Agreed To Purchase 29.7M Newly Issued Class A Ordinary Shares Of Co At A Price Of $0.175/Share

AnPac Bio-Medical Science In Dec 2022 & Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors; Investors Agreed To Purchase 29.7M Newly Issued Class A Ordinary Shares Of Co At A Price Of $0.175/Share

Anpac Bio-Medical Science在2022年12月和2023年1月与几位第三方投资者签署了最终投资协议;投资者同意以每股0.175美元的价格购买2970万股新发行的A类普通股
Benzinga Real-time News ·  2023/01/24 07:27

AnPac Bio-Medical Science In Dec 2022 & Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors; Investors Agreed To Purchase 29.7M Newly Issued Class A Ordinary Shares Of Co At A Price Of $0.175/Share

Anpac Bio-Medical Science在2022年12月和2023年1月与几位第三方投资者签署了最终投资协议;投资者同意以每股0.175美元的价格购买2970万股新发行的A类普通股

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发